Sphingolipidomics: A valuable tool for understanding the roles of sphingolipids in biology and disease

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Merrill Jr , Alfred H ^a   Stokes, Todd H ^a   Momin, Amin ^a   Park, Hyejung ^a   Portz, Brent J ^a   Kelly, Samuel ^a   Wang, Elaine ^a   Sullards, M Cameron ^a   Wang, May Dongmei ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Ceramides; Glycosphingolipids; Lipidomics; Metabolism; Sphingoid bases; Systems biology

Indexed keywords

SPHINGOLIPID;

ANIMAL; ARTICLE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHEMISTRY; GENERAL ASPECTS OF DISEASE; HUMAN; LIPID METABOLISM; METABOLISM; SYSTEMS BIOLOGY;

ANIMALS; BIOLOGICAL PHENOMENA; DISEASE; HUMANS; LIPID METABOLISM; SPHINGOLIPIDS; SYSTEMS BIOLOGY;

EID: 66349108431     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800073-JLR200     Document Type: Review

References (44)

1. Auffray, C., S. Imbeaud, M. Roux-Rouquie, and L. Hood. 2003. From functional genomics to systems biology: concepts and practices. C. R. Biol. 326: 879-892. (Pubitemid 38016443)
2. Merrill, A. H., Jr., M. D. Wang, M. Park, and M. C. Sullards. 2007. (Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends Biochem. Sci. 32: 457-468. (Pubitemid 47588946)
3. Hait, N. C., C. A. Oskeritzian, S. W. Paugh, S. Milstien, and S. Spiegel. 2006. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta. 1758: 2016-2026. (Pubitemid 44879368)
4. Chester, M. A. 1998. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids-recommendations 1997. Eur. J. Biochem. 257: 293-298.
5. Fahy, E., S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, Jr., R. C. Murphy, C. R. Raetz, D. W. Russell, Y. Seyama, W. Shaw, et al. 2005. A comprehensive classification system for lipids. J. Lipid Res. 46: 839-861.
6. Bartke, N., and Y. A. Hannun. 2009. Bioactive sphingolipids: metabolism and function. J. Lipid Res. S91-S96.
7. Zitomer, N. C., T. Mitchell, K. A. Voss, G. S. Bondy, S. T. Pruett, E. C. Garnier-Amblard, L. S. Liebeskind, H. Park, E. Wang, M. C. Sullards, et al. 2009. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxy-sphinganine: A novel category of bioactive 1-deoxy-sphingoid bases and 1-deoxy-dihydroceramides biosynthesized by mammalian cell lines and animals. J. Biol. Chem. 284: 4786-4795.
8. Pruett, S. T., A. Bushnev, K. Hagedorn, M. Adiga, C. A. Haynes, M. C. Sullards, D. C. Liotta, and A. H. Merrill, Jr. 2008. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 49: 1621-1639.
9. Hashimoto, K., S. Kawano, S. Goto, K. F. Aoki-Kinoshita, M. Kawashima, and M. Kanehisa. 2005. A global representation of the carbohydrate structures: a tool for the analysis of glycan. Genome Inform. 16: 214-222.
10. Sullards, M. C., J. C. Allegood, S. Kelly, E. Wang, C. A. Haynes, H. Park, Y. Chen, and A. H. Merrill, Jr. 2007. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics. Methods Enzymol. 432: 83-115.
11. Kirsch, S., M. Zarei, M. Cindric, J. Muthing, L. Bindila, and J. Peter-Katalinic. 2008. On-line nano-HPLC/ESI QTOF MS and tandem MS for separation, detection, and structural elucidation of human erythrocytes neutral glycosphingolipid mixture. Anal. Chem. 80: 4711-4722. (Pubitemid 351842351)
12. Ivleva, V. B., Y. N. Elkin, B. A. Budnik, S. C. Moyer, P. B. O'Connor, and C. E. Costello. 2004. Coupling thin-layer chromatography with vibrational cooling matrix-assisted laser desorption/ionization Fourier transform mass spectrometry for the analysis of ganglioside mixtures. Anal. Chem. 76: 6484-6491. (Pubitemid 39458486)
13. Vukelic, Z., A. D. Zamfir, L. Bindila, M. Froesch, J. Peter-Katalinic, S. Usuki, and R. K. Yu. 2005. Screening and sequencing of complex sialylated and sulfated glycosphingolipid mixtures by negative ion electrospray Fourier transform ion cyclotron resonance mass spectrometry. J. Am. Soc. Mass Spectrom. 16: 571-580. (Pubitemid 40410042)
14. Sommer, U., H. Herscovitz, F. K. Welty, and C. E. Costello. 2006. LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J. Lipid Res. 47: 804-814.
15. Nakamura, K., Y. Suzuki, N. Goto-Inoue, C. Yoshida-Noro, and A. Suzuki. 2006. Structural characterization of neutral glycosphingolipids by thin-layer chromatography coupled to matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight MS/MS. Anal. Chem. 78: 5736-5743. (Pubitemid 44265034)
16. Vukelic, Z., M. Zarei, J. Peter-Katalinic, and A. D. Zamfir. 2006. Analysis of human hippocampus gangliosides by fully-automated chip-based nanoelectrospray tandem mass spectrometry. J. Chromatogr. A. 1130: 238-245. (Pubitemid 44441308)
17. Merrill, A. H., Jr., M. C. Sullards, J. C. Allegood, S. Kelly, and E. Wang. 2005. Sphingolipidomics: high throughput, structure specific and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods. 36: 207-224. (Pubitemid 40726151)
18. Tserng, K. Y., and R. Griffin. 2004. Studies of lipid turnover in cells with stable isotope and gas chromatograph-mass spectrometry. Anal. Biochem. 325: 344-353. (Pubitemid 38134372)
19. Bederman, I. R., T. Kasumov, A. E. Reszko, F. David, H. Brunengraber, and J. K. Kelleher. 2004. In vitro modeling of fatty acid synthesis under conditions simulating the zonation of lipogenic [13C]acetyl-CoA enrichment in the liver. J. Biol. Chem. 279: 43217-43226. (Pubitemid 39372217)
20. Chen, Y., J. Allegood, Y. Liu, E. Wang, B. Cachon-Gonzalez, T. M. Cox, A. H. Merrill, Jr., and M. C. Sullards. 2008. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. Anal. Chem. 80: 2780-2788. (Pubitemid 351556439)
21. Hankin, J. A., R. M. Barkley, and R. C. Murphy. 2007. Sublimation as a method of matrix application for mass spectrometric imaging. J. Am. Soc. Mass Spectrom. 18: 1646-1652. (Pubitemid 47302327)
22. Sjovall, P., J. Lausmaa, and B. Johansson. 2004. Mass spectrometric imaging of lipids in brain tissue. Anal. Chem. 76: 4271-4278. (Pubitemid 39013993)
23. Roy, S., D. Touboul, A. Brunelle, D. P. Germain, P. Prognon, O. Laprevote, and P. Chaminade. 2006. [Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry's disease] Ann. Pharm. Fr. 64: 328-334.
24. Borner, K., H. Nygren, B. Hagenhoff, P. Malmberg, E. Tallarek, and J. E. Mansson. 2006. Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. Biochim. Biophys. Acta. 1761: 335-344.
25. Baker, M. J., L. Zheng, N. Winograd, N. P. Lockyer, and J. C. Vickerman. 2008. Mass spectral imaging of glycophospholipids, cholesterol, and glycophorin a in model cell membranes. Langmuir. 24: 11803-11810.
26. Kraft, M. L., P. K. Weber, M. L. Longo, I. D. Hutcheon, and S. G. Boxer. 2006. Phase separation of lipidmembranes analyzed with high-resolution secondary ion mass spectrometry. Science. 313: 1948-1951. (Pubitemid 44497999)
27. Wiseman, J.M., D. R. Ifa, Q. Song, and R. G. Cooks. 2006. Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. Angew. Chem. Int. Ed. Engl. 45: 7188-7192. (Pubitemid 44748295)
28. Nairn, A. V., W. S. York, K. Harris, E. M. Hall, J. M. Pierce, and K. W. Moremen. 2008. Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J. Biol. Chem. 283: 17298-17313.
29. Dahlquist, K. D., N. Salomonis, K. Vranizan, S. C. Lawlor, and B. R. Conklin. 2002. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31: 19-20.
30. Turashvili, G., J. Bouchal, K. Baumforth, W. Wei, M. Dziechciarkova, J. Ehrmann, J. Klein, E. Fridman, J. Skarda, J. Srovnal, et al. 2007. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 7: 55.
31. Pewzner-Jung, Y., S. Ben-Dor, and A. H. Futerman. 2006. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J Biol Chem. 281: 25001-25005. (Pubitemid 44401887)
32. Zheng, W., J. Kollmeyer, H. Symolon, A. Momin, E. Munter, E. Wang, S. Kelly, J. C. Allegood, Y. Liu, Q. Peng, et al. 2006. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim. Biophys. Acta. 1758: 1864-1884. (Pubitemid 44879367)
33. Wang, H., B. J. Maurer, Y. Y. Liu, E. Wang, J. C. Allegood, S. Kelly, H. Symolon, Y. Liu, A. H. Merrill, Jr., V. Gouaze-Andersson, et al. 2008. N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol. Cancer Ther. 7: 2967-2976.
34. Alvarez-Vasquez, F., K. J. Sims, L. A. Cowart, Y. Okamoto, E. O. Voit, and Y. A. Hannun. 2005. Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature. 433: 425-430. (Pubitemid 40203323)
35. Cowart, L. A., and Y. A. Hannun. 2005. Using genomic and lipidomic strategies to investigate sphingolipid function in the yeast heat-stress response. Biochem. Soc. Trans. 33: 1166-1169. (Pubitemid 41659141)
36. Henning, P. A., H. J. Merrill, and M. Wang. 2004. Dynamic pathway modeling of sphingolipid metabolism. Conf. Proc. IEEE Eng. Med. Biol. Soc. 4: 2913-2916. (Pubitemid 40035648)
37. Degroote, S., J. Wolthoorn, and G. van Meer. 2004. The cell biology of glycosphingolipids. Semin. Cell Dev. Biol. 15: 375-387. (Pubitemid 38781900)
38. Hakomori, S. I. 2008. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim. Biophys. Acta. 1780: 325-346.
39. Hannun, Y. A., and L. M. Obeid. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9: 139-150. (Pubitemid 351158911)
40. Alvarez, S. E., S. Milstien, and S. Spiegel. 2007. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab. 18: 300-307. (Pubitemid 47531961)
41. Urs, A. N., E. Dammer, S. Kelly, E. Wang, A. H. Merrill, Jr., and M. B. Sewer. 2007. Steroidogenic factor-1 is a sphingolipid binding protein. Mol. Cell. Endocrinol. 265-266: 174-178. (Pubitemid 46273962)
42. Han, X. 2007. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics. J. Neurochem. 103 (Suppl 1): 171-179.
43. Koybasi, S., C. E. Senkal, K. Sundararaj, S. Spassieva, J. Bielawski, W. Osta, T. A. Day, J. C. Jiang, S. M. Jazwinski, Y. A. Hannun, et al. 2004. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279: 44311-44319. (Pubitemid 39430835)
44. Holland, W. L., and S. A. Summers. 2008. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 29: 381-402. (Pubitemid 351831506)